Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Avastin (bevacizumab) in combination with fotemustine for metastatic melanoma completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Avastin (bevacizumab)
• Fotemustine (fotemustine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-25